Gil Constantino, Rivera Antonio, Bañuelos David, Salinas Salvador, García-Latorre Ethel, Cedillo Lilia
Centro de Investigaciones en Ciencias Microbiológicas, Instituto de Ciencias, Benemérita Universidad Autónoma de Puebla, Edificio 103J, Ciudad Universitaria, Puebla, Pue, México.
BMC Musculoskelet Disord. 2009 Aug 3;10:97. doi: 10.1186/1471-2474-10-97.
Increasing evidence incriminates bacteria, especially Mycoplasma fermentans, as possible arthritogenic agents in humans. The purpose of this study was to investigate M. fermentans in the bloodstream of patients with rheumatoid arthritis.
Two hundred and nineteen blood samples from patients with rheumatoid arthritis, systemic lupus erythematosus, antiphospholipid syndrome, and healthy individuals were screened by bacterial culture and direct PCR in order to detect mycoplasmas; IgM and IgG against M. fermentans PG18 were also detected by ELISA and Immunoblotting assays in patients with rheumatoid arthritis and healthy individuals.
Blood samples from patients with antiphospholipid syndrome and healthy individuals were negative for mycoplasma by culture or direct PCR. In blood samples from patients with systemic lupus erythematosus were detected by direct PCR M. fermentans in 2/50 (2%), M. hominis in 2/50 (2%) and U. urealyticum in 1/50 (0.5%). In patients with RA M. fermentans was detected by culture in 13/87 blood samples and in 13/87 by direct PCR, however, there was only concordance between culture and direct PCR in six samples, so M. fermentans was detected in 20/87(23%) of the blood samples from patients with RA by either culture or PCR. Antibody-specific ELISA assay to M. fermentans PG18 was done, IgM was detected in sera from 40/87 patients with RA and in sera of 7/67 control individuals, IgG was detected in sera from 48/87 RA patients and in sera from 7/67 healthy individuals. Antibody-specific immunoblotting to M. fermentans PG18 showed IgM in sera from 35/87 patients with RA and in sera from 4/67 healthy individuals, IgG was detected in sera from 34/87 patients and in sera from 5/67 healthy individuals.
Our findings show that only M. fermentans produce bacteremia in a high percentage of patients with RA. This finding is similar to those reported in the literature. IgM and IgG against M. fermentans PG18 were more frequent in patients with RA than healthy individuals.
越来越多的证据表明细菌,尤其是发酵支原体,可能是人类关节炎的致病因子。本研究的目的是调查类风湿关节炎患者血液中的发酵支原体。
对219份来自类风湿关节炎患者、系统性红斑狼疮患者、抗磷脂综合征患者及健康个体的血样进行细菌培养和直接PCR检测,以检测支原体;同时采用ELISA和免疫印迹法检测类风湿关节炎患者及健康个体血清中抗发酵支原体PG18的IgM和IgG抗体。
抗磷脂综合征患者和健康个体的血样经培养或直接PCR检测支原体均为阴性。系统性红斑狼疮患者的血样经直接PCR检测,发酵支原体阳性2/50例(2%),人型支原体阳性2/50例(2%),解脲脲原体阳性1/50例(0.5%)。类风湿关节炎患者的血样经培养检测发酵支原体阳性13/87例,经直接PCR检测阳性13/87例,但仅有6份样本培养和直接PCR结果一致,因此,类风湿关节炎患者血样中经培养或PCR检测发酵支原体阳性20/87例(23%)。采用发酵支原体PG18特异性抗体ELISA检测,类风湿关节炎患者血清中IgM阳性40/87例,健康对照个体血清中IgM阳性7/67例;类风湿关节炎患者血清中IgG阳性48/87例,健康个体血清中IgG阳性7/67例。发酵支原体PG18特异性抗体免疫印迹检测显示,类风湿关节炎患者血清中IgM阳性35/87例,健康个体血清中IgM阳性4/67例;类风湿关节炎患者血清中IgG阳性34/87例,健康个体血清中IgG阳性5/67例。
我们的研究结果表明,只有发酵支原体在高比例的类风湿关节炎患者中引起菌血症。这一发现与文献报道相似。类风湿关节炎患者血清中抗发酵支原体PG18的IgM和IgG抗体水平高于健康个体。